Introduction Microbial expression systems have become a cornerstone of modern biopharmaceutical manufacturing, offering faster turnaround, lower production costs, and greater scalability than traditional mammalian platforms for a wide range of biologics, including recombinant proteins, nanobodies, plasmid DNA, and nucleic acid therapeutics. As global biopharma companies and biotech startups...